- Home
- HIHO vs CHRO Comparison
HIHO vs CHRO Comparison
Compare HIHO & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIHO
- CHRO
- Stock Information
- Founded
- HIHO 1990
- CHRO 2002
- Country
- HIHO Hong Kong
- CHRO United States
- Employees
- HIHO N/A
- CHRO N/A
- Industry
- HIHO Industrial Machinery/Components
- CHRO
- Sector
- HIHO Industrials
- CHRO
- Exchange
- HIHO Nasdaq
- CHRO Nasdaq
- Market Cap
- HIHO 8.3M
- CHRO 8.4M
- IPO Year
- HIHO 1996
- CHRO 2024
- Fundamental
- Price
- HIHO $1.77
- CHRO $0.93
- Analyst Decision
- HIHO
- CHRO Strong Buy
- Analyst Count
- HIHO 0
- CHRO 1
- Target Price
- HIHO N/A
- CHRO N/A
- AVG Volume (30 Days)
- HIHO 37.6K
- CHRO 84.7K
- Earning Date
- HIHO 07-18-2025
- CHRO 05-13-2025
- Dividend Yield
- HIHO 6.74%
- CHRO N/A
- EPS Growth
- HIHO N/A
- CHRO N/A
- EPS
- HIHO N/A
- CHRO N/A
- Revenue
- HIHO $7,345,000.00
- CHRO N/A
- Revenue This Year
- HIHO N/A
- CHRO N/A
- Revenue Next Year
- HIHO N/A
- CHRO N/A
- P/E Ratio
- HIHO N/A
- CHRO N/A
- Revenue Growth
- HIHO 11.36
- CHRO N/A
- 52 Week Low
- HIHO $1.40
- CHRO $0.45
- 52 Week High
- HIHO $2.88
- CHRO $3.80
- Technical
- Relative Strength Index (RSI)
- HIHO 51.14
- CHRO 34.93
- Support Level
- HIHO $1.74
- CHRO $0.92
- Resistance Level
- HIHO $1.98
- CHRO $1.05
- Average True Range (ATR)
- HIHO 0.11
- CHRO 0.10
- MACD
- HIHO -0.01
- CHRO 0.00
- Stochastic Oscillator
- HIHO 22.58
- CHRO 6.58
About HIHO Highway Holdings Limited
Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.